Dual as safe as single antiplatelet therapy during TAVR
Surgical safety outcomes are comparable between existing dual (DAPT) and single (SAPT) antiplatelet therapy in patients undergoing transcatheter aortic valve replacement (TAVR), a recent study has found.
Dual as safe as single antiplatelet therapy during TAVR
10 Aug 2021
